Valued at USD 1.8 billion in 2024, the global oral proteins and peptides market is poised to grow to USD 3.4 billion by 2033, with a CAGR of 7.13% from 2025 to 2033, according to IMARC Group. Dominated by North America, holding a 97.8% market share in 2024, the industry is propelled by advancements in drug delivery technology and a shift toward non-invasive treatments. Factors such as... https://www.imarcgroup.com/oral-proteins-peptides-market